Sepsis in Children with Acute Lymphoblastic Leukemia

Mururul Aisyi, Fifi Dwijayanti, Reni Wigati, Haridini Intan Mahdi, Laswita Yunus, Chainurridha Chainurridha, Tri Aprilliana Wulandari


Background: Sepsis is the leading cause of morbidity and mortality in children worldwide, with around 75,000 inpatients each year and nearly 50% dying in pediatric hospitals. Acute lymphoblastic leukemia (ALL) in childhood is a malignancy originating from lymphoid progenitor cells, usually at the age of 2–6 years. Children with ALL contribute 30% to childhood cancer cases under 15 years old. Sepsis in pediatric patients increases mortality significantly. A previous study showed that the prevalence of sepsis in pediatrics is still high. Thus, this study aims to report ALL patients with sepsis in our institution.

Methods: This study was a descriptive cross-sectional study at the National Cancer Center (NCC) - Dharmais Cancer Hospital. We recruited acute lymphoblastic leukemia (ALL) patients aged 2-18 years with suspected or documented sepsis based on Systemic Inflammatory Response Syndrome (SIRS) by The International Consensus Conference on Pediatric Sepsis. The data were collected by medical records from January 2014 to December 2018.

Results: A total of 94 pediatric patients in the study included 57 males and 37 females with an average age of 5 years. The age range was 1–18 years with a median age of 5 years. The prevalence of sepsis in pediatric with ALL was 11 patients (11.7%) and 45.5% of deaths. The clinical conditions were as follows: abnormal temperature (8 [72.7%]), abnormal blood pressure, systolic (7 [63.6%]) and diastolic (7 [63.6%]), abnormal pulse rate (9 [81.8%]), abnormal respiratory rate (8 [72.7%]), and normal saturation (6 [54.5%]). We also did a laboratory check followed by all sepsis patients who had abnormal leukocytes (11 [100%]), and abnormal lymphocytes count (8 [72.7%]).

Conclusions: The mortality rate and prevalence of sepsis in children with ALL in our institution are still high. Further prospective studies are required to explore the risk factors and predictors of sepsis based on its severity and adherence of health workers to implement guidelines on patients with sepsis in the hospital.


children, developing country, leukemia, sepsis


Weiss SL, Fitzgerald JC, Pappachan J, et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015;191(10):1147–57.

Sepsis Alliance. What is Sepsis [Internet]. Sepsis Basic; 2020 [cited 2020 July 30]. Available from:

Wulandari A, Pudjiastuti P, Martuti S. Severe sepsis criteria, PELOD-2, and pSOFA as predictors of mortality in critically ill children with sepsis. Paediatr Indones. 2019;59(6):318–24.

Plunkett A, Tong J. Sepsis in Children. BMJ. 2015;350(June):1–13

Wulandari A, Martuti S, Kaswadi P. Perkembangan diagnosis sepsis pada anak. Sari Pediatr. 2018;19(4):237.

Gyawali B, Ramakrishna K, Dhamoon AS. Sepsis: The evolution in definition, pathophysiology, and management. SAGE Open Med. 2019;7:205031211983504.

UICC. New Global Cancer Data: GLOBOCAN 2018 [Internet]. 2018. Available from:

Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371(9617):1030–43.

Pound CM, Johnston DL, Armstrong R, et al. The morbidity and mortality of pediatric oncology patients presenting to the intensive care unit with septic shock. Pediatr Blood Cancer. 2008;50(5):1018–25.

Weiss SL, Fitzgerald JC, Pappachan J, et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015;191(10):1147–57.

Rivera GKMD, Raul C. Ribeiro M. Improving treatment of children with acute lymphoblastic leukemia in developing countries through technology sharing, collaboration, and partnerships. Natl Institutes Heal. 2015;7(5):649–57.

Levy MM, Artigas A, Phillips GS, et al. Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12(12):919–24.

Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA - J Am Med Assoc. 2014;311(13):1308–16.

Abdelmabood S, Fouda AE, Boujettif F, Mansour A. Treatment outcomes of children with acute lymphoblastic leukemia in a middle-income developing country: high mortalities, early relapses, and poor survival. J Pediatr (Rio J). 2020;96(1):108–16.

Pinontoan E, Mantik M, Rampengan N. Pengaruh Kemoterapi Terhadap Profil Hematologi Pada Penderita Leukemia Lomfoblastik Akut. Ilmu Kesehat Anak FK UNSRAT Manad. 2013;1(2):1–6.

Rusmawatiningtyas D, Nurnaningsih N. Mortality rates in pediatric septic shock. Paediatr Indones. 2017;56(5):304.

Goldstein B, Giroir B, Randolph A. International Consensus Conference on Pediatric Sepsis. Pediatr Crit Care Med. 2005;6:2–8.

Xiao C, Wang S, Fang F, et al. Epidemiology of pediatric severe sepsis in main PICU centers in Southwest China. Pediatr Crit Care Med. 2019;20(12):1118–25.

Shah S, Deshmukh C, Tullu M. The predictors of outcome and progression of pediatric sepsis and septic shock: A prospective observational study from western India. J Postgrad Med. 2020;66(2):67–72.

Kissoon N, Carcillo JA, Espinosa V, et al. World federation of pediatric intensive care and critical care societies: Global sepsis initiative. Pediatr Crit Care Med. 2011;12(5):494–503.

Sano H, Kobayashi R, Iguchi A, et al. Risk factors for sepsis-related death in children and adolescents with hematologic and malignant diseases. J Microbiol Immunol Infect. 2017;50(2):232–8.

Christeff N, Benassayag C, Carli-Vielle C, et al. Elevated oestrogen and reduced testosterone levels in the serum of male septic shock patients. J Steroid Biochem. 1988;29(4):435–40.

Nasir N, Jamil B, Siddiqui S, et al. Mortality in sepsis and its relationship with gender. Pakistan J Med Sci. 2015;31(5):1201–6.

Angele MK, Wichmann MW, Ayala A, Cioffi WG, Chaundry IH. Testosterone Receptor Blockade After Hemorrhage in Males. JAMA Netw open. 1997;132(6):1207–14.

Kuebler JF, Jarrar D, Toth B, et al. Estradiol administration improves splanchnic perfusion following trauma-hemorrhage and sepsis. Arch Surg. 2002;137(1):74–9.

Kumar V, Neelannavar R. Study of serum levels of CRP and procalcitonin as early marker of sepsis in children with sepsis above neonatal age group. Int J Contemp Pediatr. 2019;6(2):411.

Yoon SH, Kim EH, Kim HY, Ahn JG. Presepsin as a diagnostic marker of sepsis in children and adolescents: A systemic review and meta-analysis. BMC Infect Dis. 2019;19(1):1–11.

Lanziotti VS, Póvoa P, Soares M, et al. Use of biomarkers in pediatric sepsis: Literature review. Rev Bras Ter Intensiva. 2016;28(4):472–82.

McWilliam S, Riordan A. How to use: C-reactive protein. Arch Dis Child Educ Pract Ed. 2010;95(2):55–8.

Fioretto JR, Martin JG, Kurokawa CS, Carpi MF, Bonatto RC, Moraes MA de, et al. Comparison between procalcitonin and C-reactive protein for early diagnosis of children with sepsis or septic shock. Inflamm Res. 2010;59(8):581–6.

Bateman SL, Seed PC. Procession to pediatric bacteremia and sepsis: Covert operations and failures in diplomacy. Pediatrics. 2010;126(1):137–50.

Dierig A, Berger C, Agyeman PKA, et al. Time-to-positivity of blood cultures in children with sepsis. Front Pediatr. 2018;6(August).

Gómez B, García J, Hernández S. Guidelines and recommendations on their indications, collection, processing and interpretation. Pediatrics Emergency. 2014.

Hernández-Bou S, Álvarez Álvarez C, Campo Fernández MN, et al. Blood cultures in the paediatric emergency department. Guidelines and recommendations on their indications, collection, processing and interpretation. An Pediatr. 2016;84(5):294.e1-294.e9.

Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in african children with severe infection. N Engl J Med. 2014;364(26):599–609.

Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372(14):1301–11.

Yealy DM, Kellum JA, Huang DT, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683–93.

Peake SL, Delaney A, Bailey M, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496–506.

Whittaker S-A, Mildcelsen ME, Gaieski DE, et al. Severe sepsis cohorts derived from claims-based strategies appear to be biased toward a more severely iii patient population. Intensive Care Med. 2013;41(6):1543–54.

Umscheid CA, Betesh J, Vanzandbergen C, et al. Development, implementation, and impact of an automated early warning and response system for sepsis. J Hosp Med. 2015;10(1):26–31.

Loncarica GK, Fustiñana A, Jabornisky R. Recommendations for the management of pediatric septic shock in the first hour (part I). Arch Argent Pediatr. 2019;117(1):E14–23.

Full Text: PDF

DOI: 10.33371/ijoc.v14i4.738

Article Metrics

Abstract view : 207 times
PDF - 82 times


  • There are currently no refbacks.

Copyright (c) 2020 Indonesian Journal of Cancer

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.